Selected Engagements
Engagement record 03
Federal Vaccine Manufacturing Readiness Initiative
Engagement Overview
During the COVID-19 pandemic, technical leadership was provided in support of a national vaccine manufacturing initiative focused on strengthening endotoxin testing capabilities during accelerated production.
The RIBS Method™
Recover
Stabilize analytical capability.
- Assessed endotoxin testing operations.
- Evaluated analytical risk.
- Established immediate testing priorities.
Improve
Strengthen laboratory systems.
- Developed testing strategies.
- Established MVD and MVC.
- Improved SOPs.
- Enhanced technical review and reporting.
- Optimized laboratory workflows.
Build
Develop laboratory capability.
- Trained laboratory personnel.
- Standardized testing practices.
- Established sustainable analytical processes.
- Transferred program ownership.
Scale
Support accelerated manufacturing.
- Supported FDA inspections.
- Supported client and government audits.
- Demonstrated analytical control during accelerated manufacturing.
- Enabled sustainable long-term testing capability.
The Lasting Impact
Established robust endotoxin testing capabilities supporting critical vaccine manufacturing while developing the internal expertise necessary for continued operational success.
If this resembles your situation, the review is the place to start.
Schedule Review